Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Modelling the variable incorporation of aromatic amino acids in the tyrocidines and analogous cyclodecapeptides.

Vosloo JA, Snoep JL, Rautenbach M.

J Appl Microbiol. 2019 Aug 28. doi: 10.1111/jam.14430. [Epub ahead of print]

PMID:
31461193
2.

Xenorhabdus khoisanae SB10 produces Lys-rich PAX lipopeptides and a Xenocoumacin in its antimicrobial complex.

Dreyer J, Rautenbach M, Booysen E, van Staden AD, Deane SM, Dicks LMT.

BMC Microbiol. 2019 Jun 13;19(1):132. doi: 10.1186/s12866-019-1503-x.

3.

Tyrocidine A interactions with saccharides investigated by CD and NMR spectroscopies.

Juhl DW, van Rensburg W, Bossis X, Vosloo JA, Rautenbach M, Bechinger B.

J Pept Sci. 2019 May;25(5):e3163. doi: 10.1002/psc.3163. Epub 2019 Mar 18.

PMID:
30884009
4.

The Multifaceted Antibacterial Mechanisms of the Pioneering Peptide Antibiotics Tyrocidine and Gramicidin S.

Wenzel M, Rautenbach M, Vosloo JA, Siersma T, Aisenbrey CHM, Zaitseva E, Laubscher WE, van Rensburg W, Behrends JC, Bechinger B, Hamoen LW.

MBio. 2018 Oct 9;9(5). pii: e00802-18. doi: 10.1128/mBio.00802-18.

5.

Variants of lipopeptides and glycolipids produced by Bacillus amyloliquefaciens and Pseudomonas aeruginosa cultured in different carbon substrates.

Ndlovu T, Rautenbach M, Khan S, Khan W.

AMB Express. 2017 Dec;7(1):109. doi: 10.1186/s13568-017-0367-4. Epub 2017 May 31.

6.

Characterisation and antimicrobial activity of biosurfactant extracts produced by Bacillus amyloliquefaciens and Pseudomonas aeruginosa isolated from a wastewater treatment plant.

Ndlovu T, Rautenbach M, Vosloo JA, Khan S, Khan W.

AMB Express. 2017 Dec;7(1):108. doi: 10.1186/s13568-017-0363-8. Epub 2017 May 31.

7.

An Electrospray Ionization Mass Spectrometry Study on the "In Vacuo" Hetero-Oligomers Formed by the Antimicrobial Peptides, Surfactin and Gramicidin S.

Rautenbach M, Vlok NM, Eyéghé-Bickong HA, van der Merwe MJ, Stander MA.

J Am Soc Mass Spectrom. 2017 Aug;28(8):1623-1637. doi: 10.1007/s13361-017-1685-0. Epub 2017 May 30.

PMID:
28560564
8.

Antifungal membranolytic activity of the tyrocidines against filamentous plant fungi.

Rautenbach M, Troskie AM, Vosloo JA, Dathe ME.

Biochimie. 2016 Nov;130:122-131. doi: 10.1016/j.biochi.2016.06.008. Epub 2016 Jun 18.

PMID:
27328781
9.

Antifungal peptides: To be or not to be membrane active.

Rautenbach M, Troskie AM, Vosloo JA.

Biochimie. 2016 Nov;130:132-145. doi: 10.1016/j.biochi.2016.05.013. Epub 2016 May 24. Review.

PMID:
27234616
10.

Construction and validation of a detailed kinetic model of glycolysis in Plasmodium falciparum.

Penkler G, du Toit F, Adams W, Rautenbach M, Palm DC, van Niekerk DD, Snoep JL.

FEBS J. 2015 Apr;282(8):1481-511. doi: 10.1111/febs.13237. Epub 2015 Mar 23.

11.

Inhibition of agronomically relevant fungal phytopathogens by tyrocidines, cyclic antimicrobial peptides isolated from Bacillus aneurinolyticus.

Troskie AM, de Beer A, Vosloo JA, Jacobs K, Rautenbach M.

Microbiology. 2014 Sep;160(Pt 9):2089-101. doi: 10.1099/mic.0.078840-0. Epub 2014 Jul 4.

PMID:
24996824
12.

Detailed SAR and PCA of the tyrocidines and analogues towards leucocin A-sensitive and leucocin A-resistant Listeria monocytogenes.

Leussa AN, Rautenbach M.

Chem Biol Drug Des. 2014 Nov;84(5):543-57. doi: 10.1111/cbdd.12344. Epub 2014 Jun 30.

PMID:
24766734
13.

Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms.

Troskie AM, Rautenbach M, Delattin N, Vosloo JA, Dathe M, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2014 Jul;58(7):3697-707. doi: 10.1128/AAC.02381-14. Epub 2014 Apr 21.

14.

Optimised purification and characterisation of lipid transfer protein 1 (LTP1) and its lipid-bound isoform LTP1b from barley malt.

Nieuwoudt M, Lombard N, Rautenbach M.

Food Chem. 2014 Aug 15;157:559-67. doi: 10.1016/j.foodchem.2014.02.076. Epub 2014 Feb 26.

PMID:
24679818
15.

What Goes around Comes around-A Comparative Study of the Influence of Chemical Modifications on the Antimicrobial Properties of Small Cyclic Peptides.

Scheinpflug K, Nikolenko H, Komarov IV, Rautenbach M, Dathe M.

Pharmaceuticals (Basel). 2013 Sep 6;6(9):1130-44. doi: 10.3390/ph6091130.

16.

Self-assembling organo-peptide bolaphiles with KLK tripeptide head groups display selective antibacterial activity.

Naidoo VB, Rautenbach M.

J Pept Sci. 2013 Dec;19(12):784-91. doi: 10.1002/psc.2576.

PMID:
24243600
17.

β-sheet structures and dimer models of the two major tyrocidines, antimicrobial peptides from Bacillus aneurinolyticus.

Munyuki G, Jackson GE, Venter GA, Kövér KE, Szilágyi L, Rautenbach M, Spathelf BM, Bhattacharya B, van der Spoel D.

Biochemistry. 2013 Nov 5;52(44):7798-806. doi: 10.1021/bi401363m. Epub 2013 Oct 23.

PMID:
24151934
18.

Manipulation of the tyrothricin production profile of Bacillus aneurinolyticus.

Vosloo JA, Stander MA, Leussa AN, Spathelf BM, Rautenbach M.

Microbiology. 2013 Oct;159(Pt 10):2200-11. doi: 10.1099/mic.0.068734-0. Epub 2013 Aug 20.

PMID:
23963303
19.

Direct surfactin-gramicidin S antagonism supports detoxification in mixed producer cultures of Bacillus subtilis and Aneurinibacillus migulanus.

Rautenbach M, Eyéghé-Bickong HA, Vlok NM, Stander M, de Beer A.

Microbiology. 2012 Dec;158(Pt 12):3072-82. doi: 10.1099/mic.0.063131-0. Epub 2012 Oct 25.

PMID:
23103974
20.

A novel 96-well gel-based assay for determining antifungal activity against filamentous fungi.

Troskie AM, Vlok NM, Rautenbach M.

J Microbiol Methods. 2012 Dec;91(3):551-8. doi: 10.1016/j.mimet.2012.09.025. Epub 2012 Oct 23.

PMID:
23089670
21.

Bidirectional solid phase synthesis of a model oligoglycine bolaamphiphile and purification by rapid self-assembly.

Naidoo VB, Rautenbach M.

J Pept Sci. 2012 May;18(5):317-25. doi: 10.1002/psc.2402. Epub 2012 Mar 23.

PMID:
22447321
22.

Short cationic antimicrobial peptides interact with ATP.

Hilpert K, McLeod B, Yu J, Elliott MR, Rautenbach M, Ruden S, Bürck J, Muhle-Goll C, Ulrich AS, Keller S, Hancock RE.

Antimicrob Agents Chemother. 2010 Oct;54(10):4480-3. doi: 10.1128/AAC.01664-09. Epub 2010 Jul 26.

23.

Anti-listerial activity and structure-activity relationships of the six major tyrocidines, cyclic decapeptides from Bacillus aneurinolyticus.

Spathelf BM, Rautenbach M.

Bioorg Med Chem. 2009 Aug 1;17(15):5541-8. doi: 10.1016/j.bmc.2009.06.029. Epub 2009 Jun 21.

PMID:
19586775
24.

Quality assessment of lager brewery yeast samples and strains using barley malt extracts with anti-yeast activity.

van Nierop SN, Axcell BC, Cantrell IC, Rautenbach M.

Food Microbiol. 2009 Apr;26(2):192-6. doi: 10.1016/j.fm.2008.09.003. Epub 2008 Sep 24.

PMID:
19171262
25.

Optimised quantification of the antiyeast activity of different barley malts towards a lager brewing yeast strain.

van Nierop SN, Axcell BC, Cantrell IC, Rautenbach M.

Food Microbiol. 2008 Oct;25(7):895-901. doi: 10.1016/j.fm.2008.06.004. Epub 2008 Jun 11.

PMID:
18721679
26.

Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis.

Rautenbach M, Vlok NM, Stander M, Hoppe HC.

Biochim Biophys Acta. 2007 Jun;1768(6):1488-97. Epub 2007 Jan 26.

27.

Selective lysis of erythrocytes infected with the trophozoite stage of Plasmodium falciparum by polyene macrolide antibiotics.

Wiehart UI, Rautenbach M, Hoppe HC.

Biochem Pharmacol. 2006 Mar 14;71(6):779-90. Epub 2006 Jan 24.

PMID:
16436272
28.

Analyses of dose-response curves to compare the antimicrobial activity of model cationic alpha-helical peptides highlights the necessity for a minimum of two activity parameters.

Rautenbach M, Gerstner GD, Vlok NM, Kulenkampff J, Westerhoff HV.

Anal Biochem. 2006 Mar 1;350(1):81-90. Epub 2005 Dec 15.

PMID:
16434018
29.

Atomic force microscopy study of the effect of antimicrobial peptides on the cell envelope of Escherichia coli.

Meincken M, Holroyd DL, Rautenbach M.

Antimicrob Agents Chemother. 2005 Oct;49(10):4085-92.

30.

Cell-surface alterations in class IIa bacteriocin-resistant Listeria monocytogenes strains.

Vadyvaloo V, Arous S, Gravesen A, Héchard Y, Chauhan-Haubrock R, Hastings JW, Rautenbach M.

Microbiology. 2004 Sep;150(Pt 9):3025-33.

PMID:
15347760
31.

Impact of different wort boiling temperatures on the beer foam stabilizing properties of lipid transfer protein 1.

Van Nierop SN, Evans DE, Axcell BC, Cantrell IC, Rautenbach M.

J Agric Food Chem. 2004 May 19;52(10):3120-9.

PMID:
15137863
32.

Physiological implications of class IIa bacteriocin resistance in Listeria monocytogenes strains.

Vadyvaloo V, Snoep JL, Hastings JW, Rautenbach M.

Microbiology. 2004 Feb;150(Pt 2):335-40.

PMID:
14766911
33.
35.

The interaction of analogues of the antimicrobial lipopeptide, iturin A2, with alkali metal ions.

Rautenbach M, Swart P, van der Merwe MJ.

Bioorg Med Chem. 2000 Nov;8(11):2539-48.

PMID:
11092539
36.

A sensitive standardised micro-gel well diffusion assay for the determination of antimicrobial activity.

du Toit EA, Rautenbach M.

J Microbiol Methods. 2000 Oct;42(2):159-65.

PMID:
11018272
37.

Effect of physical exercise on plasma melatonin levels in normal volunteers.

Theron JJ, Oosthuizen JM, Rautenbach MM.

S Afr Med J. 1984 Dec 1;66(22):838-41.

PMID:
6505888
38.

Albinism in blacks--aberrant circadian plasma immunoreactive melatonin levels.

Oosthuizen JM, Theron JJ, Meyer AC, Rautenbach MM.

S Afr Med J. 1983 Oct 15;64(17):651-2. No abstract available.

PMID:
6623264
39.

[Proposal for classification of newborn infants with different birth weight and determination of the concept].

Rautenbach M, Arnold M.

Kinderarztl Prax. 1977 Sep;45(9):385-93. German. No abstract available.

PMID:
926614
40.

The second double heart transplant.

Heriza E, Norris C, Rautenbach MA.

SA Nurs J. 1975 Sep;42(9):29, 12. No abstract available.

PMID:
1105826
41.
42.

[Suggestions for a standardized program for the classification of newborn infants with low birth weight].

Rautenbach M, Hoepffner W.

Padiatr Grenzgeb. 1974;13(4):219-33. German. No abstract available.

PMID:
4457765
43.

[The intrauterine retarded newborn infant. Review and recommendations of the Society for Perinatal Medicine of the DDR. II. Etiology, pathogenesis, prenatal diagnosis, prenatal and postnatal therapy and prognosis].

Beyreibb K, Hoepffner W, Holtorff J, Krause W, Rautenbach M, Röse I, Rogner G.

Z Arztl Fortbild (Jena). 1973 May 15;67(10):481-7. Review. German. No abstract available.

PMID:
4581411
44.

[Experiences with a morphological and neurological maturation determination technic for newborn infants with low birth weight].

Hoepffner W, Rautenbach M, Winderlich K.

Acta Paediatr Acad Sci Hung. 1973;14(3):225-33. German. No abstract available.

PMID:
4785701
45.

[Cerebrospinal fluid cytology and neurological behavior of various-maturity high-risk infants with leptomeningeal hemorrhage].

Rautenbach M.

Kinderarztl Prax. 1972 Nov;40(11):490-7. German. No abstract available.

PMID:
4650220
46.

[Early diagnosis of cerebral movement disorders in high-risk children].

Rautenbach M.

Kinderarztl Prax. 1972 Sep;40(9):415-24. German. No abstract available.

PMID:
4643483
47.

[Suggestions for a standard examination program for the maturity diagnosis of newborn infants with low birth weight].

Hoepffner W, Rautenbach M.

Kinderarztl Prax. 1972 Aug;40(8):357-65. German. No abstract available.

PMID:
4637317
48.

[Value of morphological and neurological findings in the maturity diagnosis of newborn infants with low birth weight].

Hoepffner W, Rautenbach M.

Kinderarztl Prax. 1972 Aug;40(8):350-7. German. No abstract available.

PMID:
4637316
49.

["Intrauterine retarded development" of newborn infants].

Rautenbach M.

Kinderarztl Prax. 1972 Aug;40(8):338-49. German. No abstract available.

PMID:
4637315
50.

[Organization of early recongnition and treatment of children with cerebral movement disorders].

Reuter H, Rautenbach M, Rodewald I, Schlobach B.

Kinderarztl Prax. 1971 Sep;39(9):423-8. German. No abstract available.

PMID:
4257789

Supplemental Content

Loading ...
Support Center